TY - JOUR
T1 - PET/CT in the management of thyroid cancers
AU - Marcus, Charles
AU - Whitworth, Pat W.
AU - Surasi, Devaki S.
AU - Pai, Sara I.
AU - Subramaniam, Rathan M.
PY - 2014/6
Y1 - 2014/6
N2 - OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.
AB - OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.
KW - F-DOPA PET/CT
KW - FDG PET/CT
KW - Thyroid cancer
UR - http://www.scopus.com/inward/record.url?scp=84904107810&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904107810&partnerID=8YFLogxK
U2 - 10.2214/AJR.13.11673
DO - 10.2214/AJR.13.11673
M3 - Review article
C2 - 24848831
AN - SCOPUS:84904107810
VL - 202
SP - 1316
EP - 1329
JO - The American journal of roentgenology and radium therapy
JF - The American journal of roentgenology and radium therapy
SN - 0361-803X
IS - 6
ER -